Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”During IPAW 2025, I participated in a series of virtual media interviews with television and radio stations around the country to help raise awareness about the essential role of plasma donation and plasma-derived medicines.
I was grateful to be joined by Jana Mattheu, the loving mom of a primary immunodeficiency patient, and by Dr. Michael Keller, a pediatric immunologist at Children’s National Hospital.
Together, we shared how plasma donation plays a critical role in the development of these lifesaving medicines and the science behind these unique therapies.
As Jana shared her family’s emotional and moving story, it was clear to viewers that plasma-derived medicines are not just treatments, they are lifelines.
Her son’s story defines Plasma Powers Possibility – with the help of his IgG infusions, he’s been able to thrive in both school and work.
Increasing awareness of the ongoing need for plasma donors is vital to ensuring patient access and continuity of care.
And we do that by answering questions we often get, many of which we received from members of the media throughout the day:
- How is plasma donation different than blood donation?
- Who does plasma donation help?
- How does someone get started donating?
This is why International Plasma Awareness Week is so important and why awareness, advocacy, and action are carried out year-round by the Plasma Protein Therapeutics Association (PPTA) and its members.
We are also grateful for the continued collaboration of dedicated clinicians, caregivers, and advocates who share this commitment.
Visit to learn more and get involved.”

Stay updated with Hemostasis Today.
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood
-
Feb 16, 2026, 14:44Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES